Drug Pipeline

CIT-013 high dose Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT06993233
A Study With CIT-013 in HS Patients		 Trial sites expanded: 24 -> 28 locations
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06567470 A Study With CIT-013 in RA Patients Rheumatoid Arthritis Recruiting
NCT06993233 A Study With CIT-013 in HS Patients Hidradenitis Suppurativa (HS) Recruiting
Phase 1
NCT07499908 Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013 Healthy Adult Not Yet Recruiting
Sponsors Running CIT-013 high dose Trials
Citryll BV (3)
Disease Areas
Rheumatoid Arthritis (1) Hidradenitis Suppurativa (1)
Get alerts when CIT-013 high dose trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free